Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant926 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,824 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00470067 | Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer | terminated | Phase 2 | 9 | Roswell Park Cancer InstituteOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT01284075 | The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery | terminated | N/A | 10 | University of MinnesotaOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 56 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00735553 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 77 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | terminated | Phase 3 | 175 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 8 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 71 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00548418 | Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer | completed | Phase 2 | 27 | Washington University School of MedicineOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01550380 | BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers(BKM120) | withdrawn | Phase 2 | 0 | University of UtahOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01405768 | Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) | completed | Phase 2 | 56 | Washington University School of MedicineOTHER | 1 | Jul 28, 2014 | clinicaltrials |
| NCT02198365 | Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia | completed | — | 250 | Cathay General HospitalOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00610662 | Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear | withdrawn | — | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02184975 | Cold Knife Conization With and Without Lateral Hemostatic Sutures | completed | Phase 2 | 100 | Barretos Cancer HospitalOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00626561 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2014 | clinicaltrials |
| NCT00515073 | Papillary Serous Carcinoma of the Endometrium | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 3, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01492179 | Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.(PoPuLAR) | completed | Phase 4 | 60 | Örebro University, SwedenOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00835679 | Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | terminated | Early Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00495235 | Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas | completed | — | 147 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00003094 | Carotenoid Rich Diet in Treating Cervical Dysplasia | withdrawn | Phase 2 | 0 | University of California, San DiegoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT00295945 | Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer | completed | — | 240 | University of California, San FranciscoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01097252 | Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer | completed | Phase 3 | 104 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01194609 | A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer | terminated | Phase 1 / Phase 2 | 2 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00916500 | Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer | completed | Phase 2 | 71 | Korea Cancer Center HospitalOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00936598 | Sleep and Endometrial Cancer | terminated | N/A | 6 | University of PittsburghOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01338051 | The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru(PERCAPS) | completed | Phase 1 | 642 | Preventive Oncology International, Inc.OTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02116920 | HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening(PODBT) | unknown | — | 1,000 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 17, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00101192 | Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | 76 | Gynecologic Oncology GroupNETWORK | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01613521 | Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT01364844 | Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors | completed | Phase 1 | 42 | Daiichi SankyoINDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01671462 | European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | completed | — | 1,365 | Becton, Dickinson and CompanyINDUSTRY | 2 | Feb 20, 2014 | clinicaltrials |
| NCT00485355 | Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy | completed | N/A | 27 | The Cleveland ClinicOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00002493 | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | completed | Phase 3 | — | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00087100 | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00087113 | Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00967928 | Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer | withdrawn | Phase 1 | 0 | Accelerated Community Oncology Research NetworkOTHER | 0 | Feb 14, 2014 | clinicaltrials |
| NCT00030485 | Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jan 27, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Aug 25, 2014source: clinicaltrials